Agenda

16:00-16:10   Welcome & Introduction to the meeting

Dr. Carlos Núñez, Head of Urology at MD Anderson Madrid – Hospiten, Spain

Dr. Enrique Grande, Head of Oncology at MD Anderson Madrid – Hospiten, Spain

16:10-16:30   Innovative techniques for less invasive Nephrectomy

Dr. Antonio Alcaraz, Head of Hospital Clinic Barcelona, Spain

16:30-17:00   What have SURTIME and CARMENA trials changed in our real practice?

Dr. Axel Bex, Royal Free Hospital, London and The Netherlands Cancer Institute, Netherlands

17:00-17:30   ROUND TABLE Led by:

Dr. Eldiberto Fernández, San Rafael Hospital, Spain

Dr. Juan Ignacio Martínez Salamanca, Puerta del Hierro Hospital, Spain

17:30-18:00   The earthquake of data in first-line treatment of metastatic RCC. Can we do a comprehensive summary?

Dr. Javier Puente, Clínico San Carlos Hospital, Spain

18:00-18:30   ESMO 2019 guidelines on mRCC and beyond: challenges to be faced in the short term

Dr. Bernard Escudier, Gustave Roussy Institute, France

18:30-19:00   ROUND TABLE Led by:

Dr. José Ángel Arranz, MD Anderson Madrid – Hospiten, Spain

Dra. Icíar García Carbonero, Virgen de la Salud Toledo Hospital, Spain

19:00-19:10   Closing remarks

Dr. Carlos Núñez, Head of Urology at MD Anderson Madrid – Hospiten, Spain

Dr. Enrique Grande, Head of Oncology at MD Anderson Madrid – Hospiten, Spain

Para más información, info@fundacionmdanderson.es